ARK Pharma is a biotechnology company built for bold science and fearless innovation. We are developing transformative therapies that target some of the world’s most urgent health challenges — from aggressive cancers to chronic inflammatory diseases. With a multi-platform pipeline, cross-disciplinary expertise, and patient-first thinking, Read more…

Our Vision

Transforming Disease. Redefining Possibility.
Our Mission

To pioneer next-generation therapies across oncology, rheumatology, and gastroenterology — delivering bold, science-driven solutions that radically improve lives.

Therapeutic Focus
Where We’re Building the Future
Oncology
Advancing next-generation cancer therapies targeting the hardest-to-treat tumors.
Rheumatology
Transforming how autoimmune diseases are treated with precision therapies.
Gastroenterology
Delivering new solutions for inflammatory and chronic gastrointestinal diseases.
Our Pipeline
Focused Innovation. Real Progress.
Program | Indication | Modality | Stage |
---|---|---|---|
ARK-101 | Solid Tumors | Small Molecule | Preclinical |
ARK-201 | Autoimmune Arthritis | Biologic | Preclinical |
ARK-301 | Inflammatory Bowel Disease (IBD) | Small Molecule | Discovery |
ARK-X | [Future Program] | [TBD] | Research |
Core Values
The Values Guiding Our Science

Quality Assurance
ARK Pharmaceuticals adheres to GMP (Good Manufacturing Practices) to the letter, because of the committed and diligent chemists, pharmacists, and microbiologists at ARK Pharmaceuticals who collaborate well with the production division, we are confident in the quality control processes and the dependability and safety of our goods. The biological studies of the medications can be fully provided by the microbiological division. Read more…